Locations:
Search
Direct delivery of viral-based vector KB707 to the lungs may boost anti-tumor response and help overcome immune checkpoint inhibitor resistance
Phase 1 study demonstrates immune response in three quarters of patients with triple-negative breast cancer
Care paths and research initiatives aim to answer unmet clinical needs
Combining mind, body and lifestyle practices in alignment with conventional cancer treatment
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Cleveland Clinic Cancer Institute brings multidisciplinary care, precision oncology and clinical research to the United Arab Emirates
First-of-its-kind clinic for immune-related adverse events supports oncologists in managing severe side effects
New program provides prehabilitation and rehabilitation services to help patients with cancer maintain and regain function
Consult program a valuable tool that benefits both patients and clinicians
Additional fine-tuning and recruiting of new patient groups underway
Driving advances in cancer care
Advertisement
Advertisement